These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 8018826)
1. Intermediate and high grade malignant non-Hodgkin's lymphomas: preliminary results using a new combination regimen (EVE-COPEM). Battista C; Panza N; Chiurazzi B; Iodice G; Esposito G; Cocorocchio E; Bevilacqua N; Pacilio G Biomed Pharmacother; 1993; 47(4):145-54. PubMed ID: 8018826 [TBL] [Abstract][Full Text] [Related]
2. Results of treatment with high intensity, brief duration chemotherapy in poor prognosis non-Hodgkin's lymphoma. McMaster ML; Greer JP; Wolff SN; Johnson DH; Greco FA; Stein RS; Cousar JB; Flexner JM; Hainsworth JD Cancer; 1991 Jul; 68(2):233-41. PubMed ID: 1712662 [TBL] [Abstract][Full Text] [Related]
3. A brief-duration combination chemotherapy for elderly patients with poor-prognosis non-Hodgkin's lymphoma. McMaster ML; Johnson DH; Greer JP; Wolff SN; Hildreth CR; Greco FA; Hainsworth JD Cancer; 1991 Mar; 67(6):1487-92. PubMed ID: 1705861 [TBL] [Abstract][Full Text] [Related]
4. Sequential versus alternating chemotherapy for high-grade non-Hodgkin's lymphomas: preliminary results of a phase III multicentre trial. Köppler H; Pflüger KH; Eschenbach I; Pfab R; Bruntsch U; Zeller W; Steinhauer EU; Gropp C; Oehl S; Lötzke E Onkologie; 1990 Feb; 13(1):28-32. PubMed ID: 2186321 [TBL] [Abstract][Full Text] [Related]
5. Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial. Longo DL; DeVita VT; Duffey PL; Wesley MN; Ihde DC; Hubbard SM; Gilliom M; Jaffe ES; Cossman J; Fisher RI J Clin Oncol; 1991 Jan; 9(1):25-38. PubMed ID: 1702144 [TBL] [Abstract][Full Text] [Related]
6. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol]. Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405 [TBL] [Abstract][Full Text] [Related]
7. CEOP-B alternated with VIMB in intermediate-grade and high-grade non-Hodgkin's lymphoma: a pilot study. De Lena M; Ditonno P; Lorusso V; Brandi M; Timurian A; Marzullo F; Ventrella V; Pellecchia A J Clin Oncol; 1995 Apr; 13(4):953-60. PubMed ID: 7535844 [TBL] [Abstract][Full Text] [Related]
8. Randomised comparison of CHOEP versus alternating hCHOP/IVEP for high-grade non-Hodgkin's lymphomas: treatment results and prognostic factor analysis in a multi-centre trial. Köppler H; Pflüger KH; Eschenbach I; Pfab R; Birkmann J; Zeller W; Holle R; Steinhauer UE; Gropp C; Oehl S Ann Oncol; 1994 Jan; 5(1):49-55. PubMed ID: 8172793 [TBL] [Abstract][Full Text] [Related]
9. A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL). Gobbi PG; Ghirardelli ML; Avanzini P; Baldini L; Quarta G; Stelitano C; Broglia C; Loni C; Silingardi V; Ascari E Haematologica; 2000 Mar; 85(3):263-8. PubMed ID: 10702814 [TBL] [Abstract][Full Text] [Related]
10. Vincristine, doxorubicin, cyclophosphamide, prednisone and etoposide (VACPE) in high-grade non-Hodgkin's lymphoma--a multicenter phase II study. Bergmann L; Karakas T; Lautenschlager G; Jager E; Knuth A; Mitrou PS; Hoelzer D Ann Oncol; 1995 Dec; 6(10):1019-24. PubMed ID: 8750155 [TBL] [Abstract][Full Text] [Related]
12. The treatment of elderly patients with aggressive non-Hodgkin's lymphomas: feasibility and efficacy of an intensive multidrug regimen. Bertini M; Freilone R; Vitolo U; Botto B; Ciotti R; Cinieri S; Di Nota A; Di Vito F; Levis A; Orsucci L; Pini M; Rota-Scalabrini D; Todeschini G; Resegotti L Leuk Lymphoma; 1996 Aug; 22(5-6):483-93. PubMed ID: 8882962 [TBL] [Abstract][Full Text] [Related]
13. [Sequential alternating chemotherapy of highly malignant non-Hodgkin's lymphomas with VIM-Bleo and CHOP. Initial results]. Steinke B; Kraft A; Reinold HM; Heim ME; Löffler B; Heidemann E; Richter C; Josten K; Bross K; Hofmann I Onkologie; 1989 Feb; 12(1):19-21. PubMed ID: 2469999 [TBL] [Abstract][Full Text] [Related]
14. CHOP with high dose cyclophosphamide consolidation versus CHOP alone as initial therapy for advanced stage, indolent non-Hodgkin's lymphomas. Pan D; Qin J; Farber C; O'Brien J; Filippa D; Portlock CS Leuk Lymphoma; 2003 Jun; 44(6):967-71. PubMed ID: 12854895 [TBL] [Abstract][Full Text] [Related]
15. P-VEBEC: a new 8-weekly schedule with or without rG-CSF for elderly patients with aggressive non-Hodgkin's lymphoma (NHL). Bertini M; Freilone R; Vitolo U; Botto B; Pizzuti M; Gavarotti P; Levis A; Orlandi E; Orsucci L; Pini M Ann Oncol; 1994 Dec; 5(10):895-900. PubMed ID: 7535080 [TBL] [Abstract][Full Text] [Related]
16. Combination chemotherapy with adriamycin, cyclophosphamide, vincristine, methotrexate, etoposide and dexamethasone (ACOMED) followed by involved field radiotherapy induces high remission rates and durable long-term survival in patients with aggressive malignant non-Hodgkin's lymphomas: long-term follow-up of a pilot study. Rödel S; Engert A; Diehl V; Reiser M Leuk Lymphoma; 2005 Dec; 46(12):1729-34. PubMed ID: 16353313 [TBL] [Abstract][Full Text] [Related]
17. Treatment of aggressive non-Hodgkin's lymphoma with dose-intensified epirubicin in combination of cyclophosphamide, vincristine, and prednisone (CEOP-100): a phase II study. Basaran M; Bavbek ES; Sakar B; Eralp Y; Alici S; Tas F; Yaman F; Dogan O O; Camlica H; Onat H Am J Clin Oncol; 2001 Dec; 24(6):570-5. PubMed ID: 11801756 [TBL] [Abstract][Full Text] [Related]
18. Ifosfamide, epirubicin and etoposide (IEV) therapy in relapsed and refractory high-grade non-Hodgkin's lymphoma and Hodgkin's disease. Zinzani PL; Barbieri E; Visani G; Gherlinzoni F; Perini F; Neri S; Bendandi M; Ammendolia I; Salvucci M; Babini L Haematologica; 1994; 79(6):508-12. PubMed ID: 7534744 [TBL] [Abstract][Full Text] [Related]
19. Intensive weekly combination chemotherapy for patients with intermediate-grade and high-grade non-Hodgkin's lymphoma. Sweetenham JW; Mead GM; Whitehouse JM J Clin Oncol; 1991 Dec; 9(12):2202-9. PubMed ID: 1720454 [TBL] [Abstract][Full Text] [Related]
20. [Comparing CHOP, CHOP+HD-MTX,and BFM-90 regimens in the survival rate of children and adolescents with B cell non-Hodgkin's lymphoma]. Sun XF; Su YS; Liu DG; Jiang WQ; He YJ; Lin TY; Huang HQ; Zhang L; Xia ZJ; Li YH; Zhou ZM; Chen XQ; Xia Y; Zhen ZJ; Guan ZZ Ai Zheng; 2004 Aug; 23(8):933-8. PubMed ID: 15301718 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]